Skip to content

Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients

A Feasibility, Prospective, Repeated-measures Investigation to Investigate Innovations in Clinical Care in Adult and Paediatric Recipients Implanted With CE Approved Nucleus Cochlear Implants: an Umbrella Investigation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05270876
Enrollment
20
Registered
2022-03-08
Start date
2020-10-19
Completion date
2023-03-06
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Brief summary

This study is to evaluate new approaches to device fitting and diagnostics for cochlear implant users. The evaluation can be performed in the laboratory in an acute session or in real world environments with take-home device use to further validate their benefits. Each feature will be tested in a sub-study specific to that hearing care model. On average, each sub-study is expected to include approximately 20 subjects.

Interventions

DEVICECochlear Implant and sound processor device fitting paradigm or diagnostic/measurement technique

The investigational device will be a new device fitting paradigm or diagnostic/measurement technique implemented for use with the commercially available sound processor and implant.

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Masking description

Participants were masked to which fitting method they had at any point in the study

Intervention model description

Interrupted time series

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Users of a CE approved Nucleus cochlear implant, resulting in open set speech understanding * At least three months of experience with the cochlear implant. * Older than 18 years when entering the study. * Subject is fluent speaker in the language used for assessments. * Open set speech understanding sufficient to complete the study protocol as judged by the investigator. * Willing and able to provide written informed consent

Exclusion criteria

* Unable or unwilling to comply with the requirements of the clinical investigation as determined by the investigator. * Additional health factors, known to the investigator, that would prevent or restrict participation in the audiological evaluations. * Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. * Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation. * Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.

Design outcomes

Primary

MeasureTime frameDescription
Mean Difference Between Standard and Novel Fitting Method for Monosyllabic Word Scores in Quiet0 to 4 weeks after fittingThe difference between mean CNC scores (reported as percentage of correct answers) in quiet between the standard and novel fitting method

Countries

Australia, Belgium

Participant flow

Participants by arm

ArmCount
Study Cohort
Recipients of cochlear implant or suitable for implantation Recipients received standard and novel fitting methods during the study
20
Total20

Baseline characteristics

CharacteristicStudy Cohort
Age, Continuous66.5 years
Average period of CI experience5.3 years
Device type
CI24RE(CA)
1 Participants
Device type
CI24RE(CS)
1 Participants
Device type
CI512
3 Participants
Device type
CI532
11 Participants
Device type
CI612
1 Participants
Device type
CI632
3 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
5 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Mean Difference Between Standard and Novel Fitting Method for Monosyllabic Word Scores in Quiet

The difference between mean CNC scores (reported as percentage of correct answers) in quiet between the standard and novel fitting method

Time frame: 0 to 4 weeks after fitting

Population: All study recipients received the standard and novel fitting methods at different timepoints of the study.

ArmMeasureValue (MEAN)
Study CohortMean Difference Between Standard and Novel Fitting Method for Monosyllabic Word Scores in Quiet3.8 difference in percentage correct answers

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026